Proteases and HPV-Induced Carcinogenesis.

Abstract

Persistent infection with Human papillomavirus (HPV) is the main etiologic factor for pre-malignant and malignant cervical lesions. Moreover, HPV is also associated with oropharynx and other anogenital carcinomas. Cancer-causing HPV viruses classified as group 1 carcinogens include 12 HPV types, with HPV 16 and 18 being the most prevalent. High-risk HPVs express two oncoproteins, E6 and E7, the products of which are responsible for the inhibition of p53 and pRB proteins, respectively, in human keratinocytes and cellular immortalization. p53 and pRB are pleiotropic proteins that regulate the activity of several signaling pathways and gene expression. Among the important factors that are augmented in HPV-mediated carcinogenesis, proteases not only control processes involved in cellular carcinogenesis but also control the microenvironment. For instance, genetic polymorphisms of matrix metalloproteinase 1 (MMP-1) are associated with carcinoma invasiveness. Similarly, the serine protease inhibitors hepatocyte growth factor activator inhibitor-1 (HAI-1) and -2 (HAI-2) have been identified as prognostic markers for HPV-dependent cervical carcinomas. This review highlights the most crucial mechanisms involved in HPV-dependent carcinogenesis, and includes a section on the proteolytic cascades that are important for the progression of this disease and their impact on patient health, treatment, and survival.

• Authors: Gabriel Viliod Vieira, Fernanda Somera Dos Santos, Ana Paula Lepique, Carol Kobori da Fonseca, Lara Maria Alencar Ramos Innocentini, Paulo Henrique Braz-Silva, Silvana Maria Quintana, Katiuchia Uzzun Sales
• Journal: Cancers (Cancers (Basel)) Vol. 14 Issue 13 (Jun 21 2022) ISSN: 2072-6694 [Print] Switzerland
• PMID: 35804810 (Publication Type: Journal Article, Review)